Achieved $48 million and $184 million in RYTELO® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectivelyReported total ...
$7.4 million in cash expected to provide runway to complete site expansion process and patient enrollment as part of ...
Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsTryn Stimart - Chief Legal Officer, CCO, ...
MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed ...
Tax professionals warn that IRS wage garnishments may rise unexpectedly as penalties and interest accrue IRVINE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results